Legend Biotech (LEGN) is down -10.5%, or -$2.46 to $20.96.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LEGN:
- Legend Biotech Announces Preliminary Q4 2025 CARVYKTI Sales of Approximately $555 Million
- FDA draft guidance favorable for Legend Biotech, says RBC Capital
- Legend Biotech Signals 2026 Profitability Push and CARVYKTI Expansion in Updated J.P. Morgan Presentation
- Legend Biotech Marks 10,000 CARVYKTI Patients and Ramps Up Cell Therapy Capacity Ahead of 2026 Profit Push
- Legend Biotech sees cash runway beyond 2026